Introduction
The mycoplasmas (class Mollicutes) are widespread parasites of man, animals, plants and insects (Razin & Barile, 1985) . They are distinguished from other prokaryotes by the total lack of a cell wall and by their minute dimensions. In fact, they can be considered as the smallest self-replicating organisms. Some mycoplasmas, like M . genitalium, have a genome of about 600 kb, estimated to comprise less than 500 genes (Razin, 1985 a) . These organisms are, therefore, attractive candidates for genome sequencing, an initial step already taken towards achieving the ambitious goal of complete definition in molecular terms of the machinery of a selfreplicating organism (Morowitz, 1984) .
The great majority of human and animal mycoplasmas colonize the epithelial linings of the respiratory and urogenital tracts, and can be considered as typical surface parasites. The lack of a cell wall and any of the appendages, like fimbriae, associated with adhesion of other prokaryotes, points to the fact that the mycoplasma1 cell components responsible for attachment, termed adhesins, must be part of their cell membrane. Moreover, the lack of a cell wall facilitates direct contact of the mycoplasma membrane adhesins with the specific receptors on the host cell membrane, creating a condition which, in principle, could lead to fusion of the two membranes, and transfer or exchange of membrane components. While solid proof for occurrence of these events is still missing, it is clear that the close contact of the mycoplasma with the host cell membrane creates a micro-environment facilitating the accumulation of endproducts of mycoplasma metabolism, like peroxide and superoxide radicals, thereby causing oxidative damage to the host membranes (Razin, 1985b (Razin, , 1986 Almagor et al., 1986) . Adhesion of mycoplasmas to host cells is a prerequisite for colonization by the parasite and for infection. The loss of adhesion capacity by mutation results in loss of infectivity, and reversion to the cytadhering phenotype is accompanied by regaining infectivity and virulence (Krause et al., 1982 (Krause et al., , 1983 . Most of the recent studies on mycoplasma adhesion have been focused on the human pathogens M . pneumoniae and M . genitalium. Some work has also been done on adhesion of another human pathogen, Ureaplasma urealyticum (Saada et al., 1991 ; Robertson & Sherburne, 1991) . These studies have not progressed far, due to technical difficulties resulting from the extremely poor yields of ureaplasmas cultivated in vitro. Hence, this review will essentially cover the significant progress made during the last 5 years or so on the molecular characterization of the M. pneumoniae and M . genitalium adhesins and the receptor sites of their hosts. For previous comprehensive reviews on mycoplasma adhesion the reader is referred to Razin (1985 Razin ( b, 1986 and . more generalized inflammation and, by a still unknown mechanism, lead to post-infection complications such as exanthema and heart and central nervous system manifestations. In addition, M. pneumoniae infection may induce auto-antibodies, predominantly of the IgM class, including cold agglutinins to erythrocytes, and antibodies reacting with brain, lung, smooth muscle, mitotic spindle apparatus etc. ; these antibodies, apparently, are responsible for the variety of post-infection sequelae affecting the central nervous system, heart, pancreas, joints, blood etc. (for references see Jacobs, 1991) .
M. pneumoniae exhibits the typical polymorphism of mycoplasmas, but most prominent are flask-shaped elongated organisms showing a tiny tip at one of the poles. This differentiated organelle, termed the tip organelle, tip structure or terminal structure, functions as an attachment organelle. As can be seen in Fig. 1 , the tip organelle consists of an internal rod surrounded by a lucent space enclosed by the cell membrane. Meng & Pfister (1980) were the first to show that partial removal of the cell membrane by brief treatment with 1 % Triton X-100 exposes the striated rod of the tip organelle, and also reveals thin fibrils associated with it. These observations, confirmed and extended by Gobel et al. (1981) and by Kahane et al. (1985) were interpreted as the presence of a primitive cytoskeleton (also termed the Triton shell) responsible for contractibility and motility of this organism. Motility of M. pneumoniae is of a peculiar type : the organism glides on a solid surface with the tip organelle directed towards the surface in the direction of movement (Bredt, 1979) . While the mechanism of mycoplasma motility remains unclear, it is reasonable to assume that motility plays a role in the penetration of M. pneumoniae through the mucus layer covering the tracheal ciliary epithelium, with the tip organelle leading the way to reach its destination -the membrane of the epithelial cell at the base of the cilia.
M. genitalium shares several important properties with M. pneumoniae: a flask-shaped morphology with a tip organelle, and gliding motility. Immunoblots show marked serological cross-reactivity between M. genitalium and M . pneumoniae cell proteins, supported by the significant sharing of genomic sequences between the two mycoplasmas (Yogev & Razin, 1986 ). Yet, despite the marked relatedness to M. pneumoniae, there is no doubt that M. genitalium deserves the status of a separate species. This is based on the significant difference in genomic DNA content [about 33mol% guanine + cytosine (G + C) in M. genitalium, compared to 40 mol% in M. pneumoniae], DNA homology values between the two mycoplasmas lower than 8% (Yogev & Razin, 1986) , totally different genomic cleavage patterns of the two organisms ) and a marked difference in genome size. While the values reported for the M. pneumoniae genome are in the 800 kb range (Wenzel & Herrmann, 1989; Krause & Mawn, 1990; ) the genome of M. genitalium is less than 600 kb in size Colman et al., 1990b) , the smallest genome recorded for any mycoplasma and, in fact, for a self-replicating organism. Whether this extremely small genome reflects the exceptionally fastidious nature of M. genitalium is not known but is plausible. Nevertheles, despite all of the above differences, M. genitalium resembles M . pneumoniae very closely in the nature of the cell components responsible for adherence to host cells, as will be described in detail in the following sections.
Little is known about the pathogenicity of M. genitalium for man. Originally isolated by Tully et al. (198 1) from the urethral discharge of two men suffering from non-gonoccocal urethritis, this mycoplasma has been considered a possible agent of non-gonoccocal urethritis (Taylor-Robinson et al., 1985a). However, being extremely difficult to cultivate from clinical material, evidence for the role of M. genitalium in urogenital infections is still largely indirect, based on serological tests and more recently on the detection by gene probes of the organism's DNA in clinical specimens (Jensen et al., 1991) , and on experimental infections in primates (Taylor-Robinson et al., 1985 b; Tully & Baseman, 1991) . Complicating the issue is the finding of M. genitalium together with M . pneumoniae in the respiratory tract of mycoplasmal pneumonia patients and, more recently, in the synovial fluid of a patient with polyarthritis after primary pneumonia (Tully & Baseman, 1991) , indicating that M . genitalium may colonize the respiratory tract and possibly act there as a pathogen by itself or in association with M. pneumoniae.
The P1 operon, genes and proteins
The first indication of the protein nature of M. pneumoniae adhesins came from observations that mild trypsin treatment of M. pneumoniae cells abolished their ability to adhere to tracheal epithelium and erythrocytes (Hu et al., 1977; Gorski & Bredt, 1977) . Electrophoretic analysis of the treated mycoplasmas indicated the digestion of two membrane proteins. The protein with the higher molecular mass, estimated at 170-190 kDa, was named P1 (Hu et al., 1977) . Subsequent studies established that protein PI is the major adhesin of M. pneumoniae (Hu et al., 1982; Baseman et al., 1982; Feldner et al., 1982) . M . pneumoniae organisms that lack P 1, or are unable to densely cluster or properly position it at the surface of the tip organelle, fail to attach to the Krause et al., 1982) . Much of the more recent work on M. pneumoniae adhesion has centred therefore on the molecular characteristics of the P1 adhesin, making use of new molecular genetics methodology. The P1 gene was cloned and sequenced independently by Su et al. (1987) and by Inamine et al. (1988a) with essentially identical results, an outstanding feat considering the size of the gene (almost 5000 nucleotides long). Additionally, Inamine et al. (1988a, b) showed the P1 gene to be part of a three-gene operon (Table 1) .
Elucidation of the nucleotide sequence of the PI gene revealed some peculiar properties concerning the structural gene itself and the deduced amino acid composition of the encoded P1 protein. As can be seen in Table 1 the G + C content of the P1 gene is 53.5 mol%, considerably higher than the 40 mol% of the entire M . pneumoniae genome. Together with many other mycoplasmas, M. pneumoniae uses the universal stop codon UGA as a tryptophan codon (Yamao et al., 1985; Blanchard, 1990) . Thus, the P1 gene carries more UGA codons for tryptophan than UGG, the conventional tryptophan codon (Table 1) . A tRNA recognizing UGA as tryptophan has, in fact, been detected in M. pneurnoniae (Inamine et al., 1989) . As to the P1 protein, being a surface-exposed membrane protein it undergoes processing. The leader or signal sequence, cleaved and removed on protein maturation, is rather long (Table l) , resembling some mitochondria1 and chloroplast signal peptides and differing from bacterial signal peptides which are usually 20 to 40 amino acids long (Inamine et al., 1988a) . The large PI protein is completely devoid of cysteine, deduced from the P1 gene analysis and confirmed by lack of [35S]cysteine incorporation into the P1 protein during growth (Inamine et al., 1988a) . Consequently, the P1 protein is devoid of intramolecular disulphide bonding, conferring considerable flexibility to its long polypeptide chain. Another peculiar property of the P1 protein is its high proline content, particularly at the C-terminus region associated with cytadherence . This is rather unusual and may place structural restraint on the protein and thus assist in topological organization of the adhesin in the membrane (see below -Conformation of adhesins in membranes). Interestingly, other adhesins of M. pneumoniae and M. genitalium also have a high proline content (Table 1) .
The P1 operon comprises three open-reading frames : ORF-4, P 1 and ORF-6. Nucleotide sequencing indicates the absence of cysteine in ORF-6, resembling in this respect P1, while ORF-4 contains three cysteine residues (Inamine et al., 1988b) . According to its size, ORF-4 should encode a 28 kDa protein, P1 a 170 kDa protein and ORF-6 a 130 kDa protein. Since genes contained within an operon are often involved in related functions, one could predict that the ORF-4 and ORF-6 proteins may participate in M. pneumoniae adhesion. In order to characterize the proteins translated from ORF-4 and ORF-6, Sperker et al. (1991) constructed gene fusions between the N-terminus of the RNA replicase of the E. coli bacteriophage MS2 and selected regions of ORF-4 and ORF-6. The fusion proteins synthesized in E. cdi were used to immunize mice. Unfortunately, for some unknown reason, the antisera directed against ORF-4 sequences did not recognize M. pneumoniae antigens in immunoblots. The results obtained with the ORF-6 sequences were also unexpected: instead of a single 130 kDa protein, two M. pneumoniae proteins, one of 40 kDa and the other of 90 kDa, were recognized by the specific antisera. The 40 kDa protein represented the N-terminus, and the 90 kDa protein the C-terminal part of ORF-6. The simplest explanation for this finding would be that the two proteins arise from a common 130 kDa precursor by proteolytic cleavage. Yet, such a precursor was not identified in the immunoblots, even in M. pneumoniae cells from young cultures (Sperker et al., 1991) .
Both the 40 kDa and 90 kDa proteins were missing from the non-cytadsorbing avirulent B176 M. pneumoniae strain, lending support to the notion that these proteins may, indeed, be involved in adherence. Support for this idea comes also from the observation of Vu et al. (1987) that all convalescent-phase human sera reacted in immunoblots with a 90 kDa protein in all M . pneumoniae strains, except for B 176. Obviously, if the avirulent B 176 strain could be converted into a pathogenic adhering strain by transformation with ORF-6 DNA, proof for the role of the 90 kDa protein in adherence would be achieved. Until then, one can only hypothesize about its role, and more generally about the role of the proteins encoded by ORF-4 and ORF-6 of the P1 operon.
The P30 adhesin
Although P1 is regarded as the major M. pneumoniae adhesin, it is by no means the only adhesin in this mycoplasma. Baseman et al. (1987) showed that a mAb which blocked M . pneumoniae attachment to chicken erythrocytes was directed to a 32 kDa protein present in wild-type M. pneumoniae but absent from class I1 nonadhering avirulent mutants (see below -Accessory proteins). Resembling P 1, this protein is clustered at the tip organelle, and is highly immunogenic so that antibodies to it can be detected in convalescent-phase human sera, and in sera of hamsters infected with M. (1990a) to clone its gene and characterize it. As can be seen in Table 1 , the protein, designated P30, shares a number of properties with P1, notably a proline-rich C-terminus, expressed also by substantial amino acid sequence homology with the C-terminus of P1. In addition, the C-terminus of P30 contains three types of repeat sequences, each consisting of six amino acids. The function of these repeat sequences remains unknown.
Repeated Pl gene sequences and sequence divergence
The occurrence of multiple copies of partial gene sequences has been reported for many pathogenic prokaryotes and eukaryotes, providing genetic rearrangement mechanisms for inducing variation in surface antigens and adhesins. These variations facilitate evasion by the parasite of the host defence mechanisms (Yogev et al., 1991) . The P1 gene, being the gene for the major M. pneumoniae adhesin, presented itself as an obvious candidate for investigating genetic rearrangements. Su et al. (1988) employed 14 subclones spanning the entire PI gene sequence as probes in Southern blot hybridizations with genomic M. pneumoniae DNA. Approximately one-third of the P1 structural gene was present as a single copy, while the other two-thirds of the gene sequences were present as multiple copies. Hence, there is only one complete copy of the P1 gene in the M. pneumoniae genome, but sequences of this gene are distributed in other regions of the genome. Wenzel & Herrmann (1 988 a, b), working on physical mapping of the M. pneumoniae genome, also encountered the presence of repetitive DNA sequences dispersed on the genome, some of which were identified as P1 gene sequences. The picture became more complex with the finding of another type of repetitive element, this time consisting of sequences of the ORF-6 gene of the P1 operon (Colman et al., 1990a) . To clarify the issue, a comprehensive analysis of all known repeated DNA elements, as to size, copy number, distribution on the genome and conservation within strains, was carried out by Ruland et al. (1990) making use of the complete and ordered M. pneumoniae genomic library constructed by them.
The conclusions that can be drawn from the data are as follows. (i) No significant distribution patterns of the repeat elements can be seen on the genome, but a certain accumulation of the elements was observed around the P1 operon. (ii) The total size of repeats is about 50 kb, that is about 6% of the genome. As mentioned above, detection of amplified DNA sequences in a pathogenic mycoplasma is not exceptional and is not surprising by itself. However, most surprising is the large size and relatively high copy number of these elements, present in a genome considered among the smallest of selfreplicating organisms. (iii) It is hard to believe that the repeat elements, comprising 6% of the genome, do not play an important role in the life of the pathogen. Su et al. (1988) put forward several suggestions for possible functions of the repeat sequences. Accordingly, the large P1 gene consists of a mosaic of DNA segments which code for different functions. Some sequences, associated with cytadherence, may be highly specific and conserved, while others may code for more common structural-functional domains such as transmembrane domains, signal sequences etc. Gene recombination among these segments may occur. So far there is no evidence for transcription or translation of the repeating elements, neither is there any real indication for their function.
Cell 1990b) . The existence of some variations in the P1 gene could be detected only by Southern blot analysis with the entire battery of non-overlapping subclones of the P1 gene, and by P1 gene sequencing. The 25 isolates could, accordingly, be split into two groups : group I consisting of three isolates and strain M129-B16, and group I1 consisting of all other isolates. Within each of the groups the P1 nucleotide sequences were identical or different in only one nucleotide. The difference was more discernible between the two groups. Protein P1 of group I consisted of 1627 amino acids while that of group I1 consisted of 1635 amino acids. The nucleotide variations between the groups were located mostly in the multiple copy regions of the P1 genes. Su et al. (1990a) expressed surprise that despite expectations, the P1 gene revealed such a highly conserved nature. However, considering-the crucial role of the P1 adhesin in M. pneumoniae parasitism, one should not be surprised at the stability of the P1 gene. Minor sequence variations are known to occur in the highly conserved ribosomal RNA and elongation factor genes of mycoplasmas without affecting the function of their encoded products (Razin, 1985a; Yogev et al., 1988 ) so that minor variations in the P1 gene could be expected. The question is really whether these minor variations have any effect on virulence and on the immune response of the host, as proposed by Su et al. (1990a, b) . No answer to this question can be given at present. As will be discussed below, known reasons for loss of adherence in M. pneumoniae are associated with loss of accessory proteins, energized state of cells and apparent changes in membrane distribution and exposure of the P1 adhesin, rather than with changes in the P1 molecule itself.
Accessory proteins
The spontaneous appearance of non-adhering mutants of M. pneumoniae occurs at a high frequency (Krause et al., 1982 (Krause et al., , 1983 and cells with a non-adherence phenotype typically comprise more than 50% of the population of virulent M . pneumoniae cultures (Kahane et al., 1985) . The finding that P1 is usually not lost from non-adhering cells indicates that P1 alone is not sufficient for mediating cytadherence. In fact, data accumulated in the last decade show that M. pneumoniae cytadherence is a complex, multifactorial process, involving, in addition to the adhesins P1 and P30, other membrane proteins and cytoskeletal elements. Furthermore, for the complex to function metabolic energy is needed, apparently for the concentration and proper alignment of the adhesins at the tip organelle in a conformation assuring their tight binding to host cell receptors.
The cytadherence-negative mutants have been grouped into four classes (Krause et al., 1982; Stevens & Krause, 1991) . Class I consists of mutants lacking five high-molecular-mass proteins designated HM W 1 to HMWS, ranging in molecular mass from 140 to over 340 kDa (Stevens 8z Krause, 1990) . Class I1 mutants lack the P30 adhesin. Class I11 mutants lack proteins designated A, B and C (72,85 and 37 kDa, respectively), while class IV, represented by a single mutant, lacks protein P1 in addition to proteins A, B and C. In all cases, the re-acquisition of the missing protein(s) results in reversion to the adherence-positive phenotype (Krause et al., 1983) . The HMW and A, B, and C proteins were termed accessory proteins as they could not be defined as adhesins per se, but are required for the proper functioning of the adhesins.
Some progress has recently been made in elucidating the nature of the defects leading to loss of cytadherence by some of the mutants, and initial steps were taken to characterize the molecular properties of the accessory proteins. A problem recently solved concerns the absence of P1 from the class IV mutant. The defect was shown to be caused by a frameshift mutation due to an extra adenine in a stretch of normally seven adenines near the N-terminal region of the P1 gene. This frameshift mutation, caused probably by DNA polymerase slippage at the reiterated bases during DNA replication, results in early termination of protein translation . The molecular characterization of the accessory proteins has been focused on the HMW proteins. To the four HMW proteins absent from class I mutants (Krause et al., 1982) , a fifth one, HMWS, was recently added (Stevens & Krause, 1990) . This disulphide-linked protein (> 340 kDa) consists apparently of two 190 kDa subunits, probably identical with HMW2. As all the HMW proteins are lost or re-acquired simultaneously, their expression must be co-ordinately regulated (Krause et al., 1983) . Efforts have recently been made by D. C. Krause and his associates to clone and characterize the genes of the HMW proteins. Results are still fragmentary and incomplete so that definite conclusions as to the structure of the genes cannot be drawn, but it appears that the genes for HMWl and HMW3 are adjacent to each other on the M. pneumoniae genome, in line with their presumed co-ordinate expression (Ogle et al., 1991 ; .
How do the accessory proteins promote adherence? As already mentioned, clustering of P1 and P30 at the tip organelle appears vital to attachment, as clustering provides a critical concentration of adhesin molecules required for securing a stable primary association with receptor molecules on the host cells. In the non-adhering mutants PI fails to cluster at the tip organelle (Baseman et al., 19826) . Hence one can speculate that one or more of the accessory proteins plays a role in the lateral movement and concentration of the adhesin molecules at the tip organelle. How this is accomplished is still a matter for speculation. A plausible hypothesis is that to fulfil this role the accessory proteins should be associated with the mycoplasma cytoskeleton, which is responsible not only for P1 lateral movement and proper orientation, but also for changes in cell shape, cell division and motility (Razin, 1986) . In support of this notion Stevens & Krause (1991) have shown that the HMW proteins are apparently part of the cytoskeleton-like Triton shell of M. pneumoniae (see previous section -The organisms studied) and are localized primarily in the filamentous extensions of the mycoplasma cells, in proximity to the tip organelle. It could further be proposed that the P1 molecule is associated, through its C-terminus, with the cytoskeleton, an association mediated by one or more accessory proteins (Kahane et al., 1985) .
Energy is needed for the cytoskeleton to function. A 55 kDa phosphoprotein recently detected in motile Mycoplasma and Spiroplasma species, including M . pneumoniae and M . gallisepticum, may well be an important constituent of the cytoskeleton (Platt & Rottem, 1990) . Phosphorylation of the protein requires ATP and thus depends on active metabolism. It has long been known that for M. pneumoniae to adhere an energy source is needed and adherence.does not take place at 4 "C (Feldner et al., 1981) , findings which were recently confirmed by Krivan et al. (1989) who showed that only metabolically active M. pneumoniae cells bind to the sulphated receptors (see below -Receptors).
The MgPa operon, genes and proteins M . genitalium carries an adhesin which resembles very much the M. pneumoniae adhesin P1. The similarities are expressed at all levels: the structural gene, encoded protein, immunogenicity, clustering at the tip organelle etc. (Table 1 ). In short, the major M . genitalium adhesin, termed MgPa (Hu et al., 1987) can be regarded as the counterpart or analogue of P1. Like P1, the MgPa structural gene is the central gene in a three-gene operon consisting of ORF-1 (29 kDa protein), ORF-2 (1 60 kDa protein, MgPa) and ORF-3 (1 14 kDa protein). The deduced amino acid sequences of the proteins show extensive homologies with those of the homologous sequences of the P 1 operon (Inamine el al., 1989 ; Dallo et al., 1989a, 6). As with P1, the MgPa gene has more UGA than UGG codons for tryptophan, is devoid of cysteine, and has a proline-rich C-terminus (Table 1) . Approximately half of the MgPa gene sequences exist as multiple copies dispersed on the M. genitalium chromosome, again resembling findings with P1 (Dallo & Baseman, 199 1) .
Most significantly, MgPa, although smaller than P 1, exhibits significant regions of amino acid sequence homology with the latter. Thus 85% of the deduced amino acid sequence of MgPa exhibits 42% to 74% identity with regions of P1, and hydrophobicity plots of the amino acid C-termini of the two proteins are almost superimposable (Dallo et al., 1989a) . Computer matching of the deduced amino acid sequences of MgPa and P 1 (Mader et al. 1991) , using gaps and loops to achieve maximum homology, has revealed that 747 amino acids on the entire sequences of MgPa and P1 are identical, and five of the seven hydrophobic regions of the proteins are located in corresponding regions (Fig. 2) .
In the light of this remarkable sequence homology, demonstration of epitopes common to both MgPa and P1 could be expected. Epitope analysis, employing overlapping octapeptides of a P 1 region immunologically active in human M. pneumoniae infections, and of the corresponding MgPa regions, has revealed six common epitopes, but also one M. genitalium-specific and two M . pneumoniae-specific epitopes in sera of guinea pigs infected intranasally with M. genitalium or M . pneumoniae, respectively (Jacobs et al., 1991). Moreover, mAbs generated by Morrison-Plummer et al. (1987) against MgPa inhibited adhesion of M . pneumoniae, reinforcing the chemical and functional relatedness of the two adhesins. It is possible that the marked sequence homology between MgPa and P1 is also shared by the other proteins encoded by the operons MgPa and P1. An indication that this may be so is the finding that an antibody to a protein(s) encoded by ORF-6 of the P1 operon cross-reacted with a M. genitalium protein of 118 kDa, the size expected for ORF-3, the open-reading frame in the MgPa operon corresponding in position to ORF-6 (Sperker et af., 1991). Repetitive DNA sequences of MgPa origin (see above) appear also to be present in the M. genitalium genome (Dallo & Baseman, 1991 ). An MgPa probe hybridized not only with the M. genitalium DNA fragment carrying the MgPa gene, but also, though significantly less effectively, with a number of other genomic DNA fragments (Colman et af., 1990a) .
The striking similarities between the MgPa and P1 adhesins led Dallo et al. (1989a, b) to suggest that the two proteins may be the product of an ancestral gene that underwent a horizontal gene transfer event. They went further to propose that the apparently conserved regions in the two adhesins provide an explanation for the finding of both M. genitafium and M . pneumoniae in the human respiratory tract (Baseman et af., 1988) , assuming that tissue tropism may be the consequence of similar receptor-dependent interactions mediated by these two adhesins.
Conformation of adhesins in membranes
Having at hand the complete amino acid sequence of the P1 protein enabled a computerized analysis of the sequence to be made in order to predict the molecular topography of P1. Since all computer predicting methods are based on parameters such as hydrophilicity, hydrophobicity and flexibility of protein segments, the topographical information gained should be considered as indicative rather than definitive, and is limited to a two-dimensional profile of the protein. Even if, for example, all membrane-spanning segments of the P1 protein are identified by the computer method (Figs 2 and 3), the structure of regions exposed on the cell surface or facing the cytoplasm has still to be determined. Therefore, the computer predictions of the P1 protein structure helped to provide the first clues for probable antigenic regions (based on hydrophilic or flexible segments) but could not replace the need for classical experimental approaches to provide a more definite determination of the P1 protein topography.
One of the established computer prediction methods to define the topology of membrane-spanning segments involves determining hydrophobic amino acid sequences with a favourable alpha helix structure. Using the hydrophobic moment plot of Eisenberg et a f . (1984) , six hydrophobic membrane-embedded segments of the mature P1 protein (M1 to M6) were calculated in addition to an hydrophobic segment in the signal peptide sequence, which is cleaved and eliminated during the P1 maturation process (Fig. 3) . Interestingly, comparison of the topographical features of the P1 protein with those of the MgPa protein of M. genitafium reveals that the two resemble each other in the location of the hydrophobic segments M1 and M2 (Fig. 2) . The most hydrophobic segments predicted in both P1 and MgPa are found in the C-terminal region, indicating the strong association of this region with the membrane. On the other hand, the hydrophilic and flexible segments (Hopp & Woods, 1981; Karplus & Schulz, 1985) are often found to correlate with extracellular and antigenic sites. Running the computer programs for the P1 amino acid sequence revealed that all hydrophilic and flexible regions are located in front or following the Ml-M2 hydrophobic area, indicating that most of the P1 protein might be exposed on the external cell surface, whereas the almost uncharged, proline-rich and inflexible C-terminus is apparently facing the cytoplasmic compartment (see Fig. 4) .
To evaluate and supplement the computer based data, peptides (15 to 20 amino acids long) of the computerpredicted hydrophilic and flexible P1 regions, a peptide of the N-terminus and two peptides of the C-terminus (Fig. 3) were synthesized and used to produce monoclonal and polyclonal antisera in mice. By immunofluorescence all the antisera, except for those directed against the C-terminus peptides, gave a positive signal with freshly harvested, live M. pneumoniae cells. In addition, proteolysis experiments with carboxypeptidase Y showed the C-terminus to be cleaved only when present in inside-out vesicles but not in live mycoplasma cells (E. Jacobs, unpublished data). Both approaches thus support the computer predictions that the C-terminus of P1 is facing the cytoplasm.
Anti-P1 antibodies are not only useful for topographic studies, but can also be applied to epitope mapping of distinct functions. For this purpose anti-P1 mAbs which inhibit M. pneumoniae adherence to hamster epithelial cells and to erythrocytes were produced (Dallo et af., 1988; Jacobs et af., 1989; Gerstenecker & Jacobs, 1990) . The P1 protein was isolated and purified from M. pneumoniae cells (Jacobs et al., 1988 b) , and chemically cleaved by cyanogen bromide. The cleaved fragments were separated by two-dimensional PAGE and transferred to nitrocellulose. The separated peptide spots were tested for mAb binding. Peptides showing a positive immunoblot reaction with the adherence-inhibiting mAbs were cut out of the nitrocellulose membrane to sequence their N-terminal end by Edman degradation (Jacobs et af., 1989) . The results of these experiments revealed at least two regions of the P1 protein reacting with the cytadherence-inhibiting mAbs (the N-region and the D1-region in Fig. 3 ). In addition, a third region (D2-region), positioned ahead of the hydrophobic M6-region, was found by Dallo et af. (1988) to react with adherence-inhibiting mAbs. More detailed studies, using overlapping synthetic octapeptides of different regions of the P1 protein, defined the mAb-binding sites in a more refined manner (Gerstenecker & Jacobs, 1990) . The epitope-mapping experiments have led to the suggestion that the N-terminal region, the D1-domain and the D2-domain are arranged in such a close manner to enable the three different loops to fold under in uiuo conditions and form a 'triangular-complex' which would exhibit stronger adherence capacity due to co-operative binding to the receptor molecule (Gerstenecker & Jacobs, 1990) . Fig. 4 presents a model illustrating the above hypothesis (Jacobs, 1991 ). This P1 model implies an adhesin receptor interaction which is different from that of fimbrial E. coli adhesin proteins in which the adhesin binding sites consist of rather rigid sequential amino acid sequences (Hacker, 1990 
Mycoplasma gsLlisepticum adhesins
There was extensive research on adhesion of the avian respiratory pathogen M. gallisepticum in the 1970s and early 1980s (Razin, 1985 (Razin, b, 1986 ) but the emphasis is now on studying adhesion of the human pathogenic mycoplasmas. Nevertheless, the availability of cloned genes and specific antibodies to the M. pneumoniae and M . genitalium adhesins prompted Dallo 8z Baseman (1 990) to apply these reagents to M. gallisepticum cells, found previously to share with the two human mycoplasmas protein epitopes (Clyde 8z Hu, 1986) , genomic sequences (Yogev 8z Razin, 1986 ) and sialoglycoconjugate receptors for adhesion (Baseman et al., 1982a; Loomes et al., 1984) . The antiserum to PI reacted in immunoblots with a 155 kDa protein of M. gallisepticum, and the cloned P1 and MgPa genes hybridized in Southern blots with genomic M. gallisepticum DNA, indicating the presence in M. gallisepticum of nucleotide sequences homologous to those of P1 and MgPa. These findings led Dallo 8z to propose that the three phylogenetically related mycoplasmas share a family of adhesinrelated genes. However, until the presumed 155 kDa adhesin of M. gallisepticum is characterized further, no definite conclusion can be drawn as to the validity of the above suggestion. Certainly, the presumed M. gallisepticum adhesin appears to differ significantly in its molecular properties from P1 and MgPa, as cytadherence-inhibiting mAbs to P1 and MgPa do not react with the M. gallisepticum 155 kDa protein, and the subclone of the P1 gene that encodes the 13 amino acid sequence mediating cytadherence does not hybridize with M. gallisepticum DNA, even under low stringency conditions.
Receptors
The role of sialoglycoconjugates of host cell surfaces as receptors for M. pneumoniae, M. genitalium, M . gallisepticum and M . synoviae has long been established (for references see Razin, 1985 Razin, b, 1986 . Loomes et al. (1984, 1985) showed that M. pneumoniae receptors on human erythrocytes were glycoproteins and glycolipids with carbohydrate structures consisting of a2-3-sialylated poly( N-acetyllactosamine) sequences. More recent work by Roberts et al. (1989) has confirmed the role of sialylated glycoproteins as receptors for M. pneumoniae, defining the active proteins as those carrying terminal NeuAc(a2-3)Gal( /? 1 -4)GlcNAc sequences.
Nevertheless, neuraminidase treatment has frequently failed to abolish completely, or even partially, the ability of various eukaryotic cells to bind M. pneumoniae Geary 8z Gabridge, 1987) , prompting a search for additional receptor molecules. This search, based on measuring binding of labelled M. pneumoniae cells to purified glycolipids or glycoproteins adsorbed to a solid surface, has indicated that sulphated glycolipids containing terminal Gal( 3S04)/?1 -residues function as receptors ; obviously, these are insensitive to neuraminidase . Moreover, a sialic-acidfree glycoprotein, isolated from cultured human lung fibroblasts, has also been shown to serve as a receptor for M. pneumoniae (Geary et al., 1990) .
Clearly, there is more than one type of receptor for M. pneumoniae, and apparently for other adhering mycoplasmas as well. This should not come as a surprise considering that each mycoplasma may carry more than one adhesin type. Thus M. pneumoniae has at least two adhesins, P1 and P30 (Table 1) . This notion finds support in the finding of Geary et al . (1990) that the glycoprotein receptor isolated from lung fibroblasts binds specifically to a 32 kDa protein of M. pneumoniae, a 90 kDa protein of M. genitalium and a 139 kDa protein of M. gallisepticum. Hence the major adhesins of M. pneumoniae and M . genitalium, PI and MgPa, do not seem to recognize this glycoprotein 'receptor'. It could be argued that this glycoprotein recognizes the 30 kDa (P30) adhesin of M. pneumoniae (Table 1) . A possible way to examine this proposal would be to test purified adhesins for their binding to prospective receptor molecules, utilizing the methodology of Krivan et al. (1989) and Roberts et al. (1989) .
Identification of the sialo-oligosaccharide type of receptors for M. pneumoniae enabled Loveless & Feizi (1989) to apply sequence-specific mAbs and lectins to demonstrate in situ the receptor structures for M. pneumoniae at the primary site of infection, the human bronchial epithelium. While the apical microvillar border and the cilia carried the receptors, the secretory cells and mucus lacked them, favouring attachment of the pathogen to the ciliated cells and avoiding the secreted mucus barrier.
Immunogenicity of adhesins and vaccine engineering
In order to test the idea of using P1 or MgPa as vaccinogens, ways have to be devised to prepare these adhesins in large quantities. Being hydrophobic integral membrane proteins hampers their isolation and purification, and in addition one has to take into account the high cost and great difficulties of cultivating M. pneumoniae and, more so, M. genitalium. Purified P1 has been isolated from M. pneumoniae cells either by immunoaffinity chromatography followed by SDS-PAGE and elution (Su et al., 1987) or by electroelution of the P1 band from SDS-PAGE (Jacobs et al., 19876, 19886) . By both procedures the yield of P1 is about 1 % of the total M. pneumoniae cell protein, making the product a most expensive one. This naturally led to the idea of expressing the P1 and MgPa genes in E. coli. Unfortunately, this approach encountered a serious problem. The usage by Mycoplasma, Ureaplasrna and Spiroplasma species of the universal stop codon UGA as a tryptophan codon (for references see Blanchard, 1990 ) hinders the expression in E. coli of mycoplasmal messages. This is particularly true for genes like P1 and MgPa, which carry more UGA than UGG codons (Table l) , explaining the production of truncated rather than complete adhesin proteins in E. coli transfected with these genes (Trevino et al., 1986; Schaper et al., 1987) . Possible ways to overcome this problem include the use of suppressor E. coli strains found to be effective in the expression of a spiroplasmal DNA methylase gene (Renbaum et al., 1990) . Another way is to convert in vitro TGA to UGG in mycoplasmal genes by site-directed mutagenesis, an approach employed by Li et al. (1990) in the development of a recombinant adenovirus vaccine containing P1 gene inserts (see below). Yet, despite the expected difficulties resulting from the UGA codon problem, fusion proteins containing large moieties of M . pneumoniae (Trevino et al., 1986; Ogle et al., 1991) and M . genitalium proteins can be obtained, using the expression vector Agt 1 1. It should be mentioned that the mycoplasmal gene inserts may contain not only UGA but also the conventional UGG codons for tryptophan. In this way fusion proteins with antigenic moieties common to the adhesins of both M. genitalium and M . pneumoniae have been obtained .
The main antigenic components of M. pneumoniae cells are proteins and glycolipids. Antibodies directed against the P1 protein are regularly found in patients with acute M. pneumoniae infections (Jacobs et al., 1987a; Vu et al., 1987) . Since the P1 adhesin functions also as a major antigen of M. pneumoniae cells, antiadhesin antibodies are expected to inhibit the adherence of M . pneumoniae to host cells and protect against infection, promoting the idea of using the P1 protein as a vaccinogen (Razin, 1986) . Guinea pigs have been immunized with the purified P1 protein systemically by intraperitoneal injections (Jacobs et al., 1988 c) or intranasally in order to induce a more local antibody response (Jacobs et al., 1988a) . These animal studies have confirmed that the P1 protein is an effective antigen, eliciting strong systemic and local antibody responses, so that the vaccinated animals should be protected against a subsequent infection with live M . pneumoniae. In fact, the number of mycoplasmas in bronchial washings of immunized guinea pigs challenged with virulent M. pneumoniae was much smaller compared to unvaccinated challenged animals. However, lung tissues of the immunized guinea pigs showed no reduction of lympho-histiocyte infiltrations around bronchi and small vessels. In some cases, the immunized and challenged animals revealed an exacerbation of the cell-mediated response, indicating that enough mycoplasma antigen was still present to maintain the cellular immune response. Interestingly, exacerbation of clinical syndromes is also observed in children and young adults with a prior history of a M. pneumoniae disease and subsequent infection with M. pneumoniae. Hence the P1 adhesin, as well as the MgPa adhesin of M. genitalium , is a potent immunogen inducing a strong antibody response but also a specific but undesired strong cellular response, making vaccination with purified P 1 protein potentially harmful. Furthermore, the animal studies as well as observations showing that immunocompetent persons with significant titres of anti-P1 antibodies are not protected from a second M. pneumoniae infection also discourage the use of the P1 protein as a vaccine candidate.
The answer to the above, somewhat unexpected, results was found on testing of patients with M. pneumoniae disease and of animals experimentally infected with M. pneumoniae (Jacobs et al., 1985; . Less than 3% of the specific anti-M. pneumoniae antibodies in the sera of men or animals exhibiting high anti-P 1 antibodies showed attachmentinhibiting activity. It was, therefore, suggested that the PI protein induces anti-PI antibodies which are mostly not directed to the major adherence-mediating epitopes but to other more immunogenic sites of the P1 amino acid sequence. To test this suggestion, patients' sera were examined for anti-M. pneumoniae antibody responses to overlapping synthetic octapeptides deduced from the amino acid sequence of the P1 protein (Jacobs et al., 1990a) . These mapping experiments clearly showed that most of the antibodies in the patients' sera did not react with the P1 regions involved in adherence. One of the two immunodominant regions with a significant number of anti-P1 epitopes is clearly separated from the adherence-mediating D1-domain (Fig. 3) . Within the second immunodominant region (the D2-domain), an amino acid sequence was found which showed both binding of patients' antibodies and binding of adherence-inhibiting antibodies; other epitopes in this region showed no overlap of this type (Fig. 3) . It thus appears that the adherence-mediating epitopes may be less antigenic in man than the other P1 epitopes. Therefore, repeated infections are necessary to build up a satisfactory level of antibody.
With this information available, the best strategy to follow appears to be the development of a P1 vaccine which should induce, on the one hand, a strong adherence inhibiting activity, but on the other hand should induce only a low but specific cell-mediated immunity so as to avoid adverse effects, i.e. the exacerbation of cell responses during a second contact with the M. pneumoniae antigen. Two approaches to vaccine development are now under study. One approach is based on the idea of establishing a mainly local immunity using a recombinant P 1-adenovirus oral vaccine (Li et al., 1990) . The live recombinant viruses will replicate in the mucosal layer of the gut and continuously produce the P 1 immunogen. Activated lymphocytes produced at the gut-associated lymph nodes would migrate to the respiratory tract, and protect the immunized subjects. The expression of specific P1 epitopes by the recombinant virus can be controlled by the P1 gene sequences incorporated into the recombinant. Obviously, selection of the sequences should include adherence-mediating epitopes, while avoiding too many T-cell-stimulating epitopes. The second approach is directed at developing a synthetic vaccine constructed of short amino acid sequences wrapped up in liposomes for intranasal application (Jacobs, 1990) . The peptides selected will be those characterized as adherence-mediating epitopes. In addition, the vaccine should include a minimum sequence of the P1 protein consisting of one T-cell-stimulating epitope, linked to a B-cell epitope which together will be able to induce an antibody response. Linking covalently the B-and T-cellstimulating amino acid sequence to the less immunogenic adherence-mediating sequences is expected to enhance antibody response to the latter. On screening the P1 protein sequence for T-and B-cell epitopes, a sequence of 11 amino acids, which includes components of both a T-and a B-cell epitope was characterized (Jacobs et al., 1990b) , so that both the adherencemediating epitopes and the T-and B-cell epitope are now available for vaccine construction and trial.
Adhesins as diagnostic probes
The P1 and MgPa adhesins have the potential to serve as diagnostic probes for the following reasons: (i) the P1 and the MgPa proteins are immunodominant antigens, eliciting strong humoral responses ; (ii) both proteins are exposed on the mycoplasma cell surface, and can thus be easily labelled with anti-adhesin antibodies; and (iii) the nucleotide sequence of the two adhesin genes is known, facilitating the use of specific sequences of these genes as probes in polymerase-chain reactions (PCRs).
The conventional serodiagnostic approach based on complement fixation with the glycolipid antigen of M. pneumoniae suffers from the low specificity of this antigen (Tully & Baseman, 1991 ; Jacobs, 1991) . A search was therefore carried out to identify a specific M. pneumoniae protein antigen to replace the glycolipid. ELISA tests with purified PI showed that this protein may serve as an adequate antigen, as antibody responses to the highly immunogenic P1 were found in all patients with M. pneumoniae infections (Jacobs et al., 1986 ). Moreover, the major advantage is the much higher specificity of the P1 antigen as compared to the glycolipid extract (Jacobs et al., 1987a) . Although the P1 protein of M. pneumoniae shares homologous amino acid sequences with the MgPa protein of M. genitalium, crossreactions between these two antigen preparations are weak . Now that the amino acid sequences of both adhesins are known, as well as their common and the different epitopes, it is possible to synthesize oligopeptides to be used as specific antigens in serological tests (Jacobs et al., 1990a; . Oligopeptides with epitopes common to M. pneumoniae and M. genitalium may be used to facilitate the serological screening of mycoplasma infections of the respiratory tract, considering that M. genitalium may also be present there . Species-specific epitopes may be used for epidemiological purposes or for serodiagnosis of possible urogenital tract infections by
M. genitalium.
For the more rapid diagnosis required for selecting effective treatment of the patient, two different diagnostic approaches are currently under clinical testing to replace the extremely slow and expensive culture techniques. The first approach is based on detection of M. pneumoniae in clinical specimens by specific anti-P1 monoclonal or polyclonal antibodies. These antibodies, coated onto ELISA plates, are used to capture PI molecules out of solubilized material (nasopharyngeal aspirates, bronchial washings or sputum) from patients. The 'captured' P1 protein is detected with enzymeconjugated anti-P1 or with anti-M. pneumoniae antibodies Gerstenecker & Jacobs, 1992) . The second approach is using PCR to detect M. pneumoniae or M . genitalium in clinical specimens. Primers of P1 or MgPa gene sequences flanking the regions to be amplified are used for amplification of the target sequence (Bernet et al., 1989; Jensen et al., 1991) . There can be little doubt that these new rapid diagnostic techniques will become a standard repertoire of the routine diagnostic laboratory. Thus basic research, focused primarily on mechanisms of adhesion and pathogenicity of mycoplasmas, is finding application now in the development of new strategies for diagnosis and prevention of mycoplasma diseases in man.
Conclusions
Concentrating research efforts on adhesion of M. pneumoniae and M . genitalium has paid off. The molecular properties of the major adhesins of these mycoplasmas, P1 and MgPa, as well as the chemical composition of host cell receptors have been defined. The topography of the large adhesin molecules embedded in the mycoplasma membrane, as predicted by computer analysis of amino acid sequences, has been supplemented by epitope mapping using mAbs acting on adhesin molecules in situ, or on synthetic oligopeptides corresponding to defined segments of the adhesin molecules. Regions of adhesin molecules inducing cytadhesion-inhibiting antibodies have been defined in this way.
The definition of adhesin epitopes has opened the way for constructing M. pneumoniae vaccines based on the P1 molecule, or on defined portions of it. As the injection of entire PI molecules causes exacerbation of host cell responses in experimental animals, efforts are now being put into selecting P1 peptide sequences having no adverse effects. This may be achieved by synthesizing oligopeptides with the required P1 epitopes, or by inserting the appropriate P1 gene segments into a recombinant advenovirus, to serve as a live vaccine. Synthetic PI oligopeptides and species-specific PI and MgPa gene sequences are also in the process of being introduced as probes in the diagnosis of M. pneumoniae and M . genitalium infections.
Cytadhesion of the mycoplasmas is a complex, multifactorial process involving, in addition to the major adhesins, a number of 'accessory' membrane proteins acting in concert with cytoskeletal elements to facilitate the lateral movement and concentration of the adhesin molecules at the attachment tip organelle of M . pneumoniae and M. genitalium. Information on this apparently complex network is meagre, and much remains to be resolved.
Oxidative damage to the host cell membrane by peroxide and superoxide radicals excreted by the adhering mycoplasmas appears to be experimentally well-substantiated. However, the possibility that the close contact of the mycoplasma membrane with that of the host leads to local and transient fusion of the two membranes, or to exchange of membrane components is intriguing, and should be investigated.
M. pneumoniae and M . genitalium are not the only mycoplasmas pathogenic to man, and there are many animal mycoplasmas that depend on adhesion to host tissues for colonization and infection. It can be expected that the lessons learned from the intensive studies on M. pneumoniae and M . genitalium adhesion will be applied to define the adhesion systems in other pathogenic mycoplasmas.
